Human embryonic kidney cells (HEK-293 cells): Characterization and dose-response relationship for modulated release of nerve growth factor for nerve regeneration

Plastic and Reconstructive Surgery

Volumn 113, Issue 2, 2004, Pages 605-610

  Jimenez, Juan Carlos ^b   Tyson, Darren R ^b   Dhar, Sanjay ^b   Nguyen, Thang ^b   Hamai, Yousuke ^b   Bradshaw, Ralph A ^b   Evans, Gregory R D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ECDYSONE; NERVE GROWTH FACTOR; PONASTERONE A; DRUG DERIVATIVE; ECDYSTERONE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CLONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; HUMAN; HUMAN CELL; NERVE REGENERATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SCAR FORMATION; SKIN FIBROBLAST; TISSUE ENGINEERING; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENETIC ENGINEERING; GENETIC TRANSFECTION; GENETICS; IN VITRO STUDY; KIDNEY; NEURITE; PHYSIOLOGY; SECRETION;

CELL DIFFERENTIATION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECDYSTERONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC ENGINEERING; HUMANS; KIDNEY; NERVE GROWTH FACTOR; NERVE REGENERATION; NEURITES; TRANSFECTION;

EID: 1442313203     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000101066.76548.E8     Document Type: Article

References (18)

1. Patrick, C. W., Jr., Zheng, B., Schmidt, M., et al. Dermal fibroblasts genetically engineered to release nerve growth factor. Ann. Plast. Surg. 47: 660, 2001.
2. Patrick, C. W., Jr., Zheng, B., Wu, X., et al. Muristerone A-induced nerve growth factor release from genetically engineered human dermal fibroblasts for peripheral nerve tissue engineering. Tissue Eng. 7: 303, 2001.
3. Invitrogen. Precise control of inducible expression in mammalian cells (Product insert). Carlsbad, Calif.: Invitrogen, 1998.
4. Raffioni, S., Zhu, Y. Z., Bradshaw, R. A., and Thompson, L. M. Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC-12 cells: A model for the control of receptor tyrosine kinase activation. J. Biol. Chem. 273: 35250, 1998.
5. Invitrogen. Lipofectamine 2000: Unsurpassed transfection efficiency and high levels of protein expression (Product insert). Carlsbad, Calif.: Invitrogen, 2002.
6. Doupe, A. J., Landis, S. C., and Patterson, P. H. Environmental influences in the development of neural crest derivatives: Glucocorticoids, growth factors, and chromaffin cell plasticity. J. Neurosci. 5: 2119, 1985.
7. Tischler, A. S., and Greene, L. A. Phenotypic plasticity of pheochromocytoma and normal adrenal medullary cells. Adv. Biochem. Psychopharmacol. 25: 61, 1980.
8. Everill, B., and Kocsis, J. D. Nerve growth factor maintains potassium conductance after nerve injury in adult cutaneous afferent dorsal root ganglion neurons. Neuroscience 100: 417, 2000.
9. Rahimi, O., and Juliano, S. L. Transplants of NGF secreting fibroblasts restore stimulus-evoked activity in barrel cortex of basal-forebrain-lesioned rats. J. Neurophysiol. 86: 2081, 2000.
10. Shoemaker, S. E., Kudwa, A. E., and Isaacson, L. G. Sympathetic ingrowth to the trigeminal ganglion following intracerebroventricular infusion of nerve growth factor. Brain Res. 956: 136, 2002.
11. Pagnotta, A., Tos, P., Fornaro M., et al. Neurotrophins and their receptors in early axonal regeneration along muscle-vein-combined grafts. Microsurgery 22: 300, 2002.
12. Menderes, A., Yilmaz, M., Vayvada, H., et al. Effects of nerve growth factor on the neurotization of denervated muscles. Ann. Plast. Surg. 48: 415, 2002.
13. Skaper, S. D. Nerve growth factor: A neurokine orchestrating neuroimmune-endocrine functions. Mol. Neurobiol. 24: 183, 2001.
14. Dekker, A. J., Winkler, J., Ray, J., et al. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience 60: 299, 1994.
15. Dekker, A. J., Fagan, A. M., Gage, F. H., and Thal, L. J. Effects of brain-derived neurotrophic factor and nerve growth factor on remaining neurons in the lesioned nucleus basalis magnocellularis. Brain Res. 639: 149, 1994.
16. Dekker, A. J., Gage, F. H., and Thal, L. J. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: Evaluation of the involvement of different neurotransmitter systems. Neuroscience 48: 111, 1992.
17. Sakiyama-Elbert, S. E., and Hubbell, J. A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J. Control. Release 69: 149, 2000.
18. Blesch, A., Uy, H. S., Diergardt, N., and Tuszynski, M. H. Neurite outgrowth can be modulated in vitro using a tetracycline-repressible gene therapy vector expressing human nerve growth factor. J. Neurosci. Res. 59: 402, 2000.